Advertisement

Table of Contents

September 01, 1992; Volume 42,Issue 3

You have access
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
B Giros, S el Mestikawy, N Godinot, K Zheng, H Han, T Yang-Feng and M G Caron

Molecular Pharmacology September 1992, 42 (3) 383-390;
You have access
Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.
T M Palmer, K A Jacobson and G L Stiles

Molecular Pharmacology September 1992, 42 (3) 391-397;
You have access
Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins.
S F Law and T Reisine

Molecular Pharmacology September 1992, 42 (3) 398-402;
You have access
Characterization of rat white fat cell alpha 1B-adrenoceptors.
M E Torres-Márquez, M T Romero-Avila, C González-Espinosa and J A García-Sáinz

Molecular Pharmacology September 1992, 42 (3) 403-406;
You have access
Stimulation of high affinity gamma-aminobutyric acidB receptors potentiates the depolarization-induced increase of intraneuronal ionized calcium content in cerebellar granule neurons.
G De Erausquin, G Brooker, E Costa and W J Wojcik

Molecular Pharmacology September 1992, 42 (3) 407-414;
You have access
Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression.
M C Mhatre and M K Ticku

Molecular Pharmacology September 1992, 42 (3) 415-422;
You have access
Gate-dependent blockade of sodium channels by phenothiazine derivatives: structure-activity relationships.
V Bolotina, K R Courtney and B Khodorov

Molecular Pharmacology September 1992, 42 (3) 423-431;
You have access
Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.
R A Lahti, L M Figur, M F Piercey, P L Ruppel and D L Evans

Molecular Pharmacology September 1992, 42 (3) 432-438;
You have access
Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
S A Veldman and M J Bienkowski

Molecular Pharmacology September 1992, 42 (3) 439-444;
You have access
Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
M M Belcheva, J Barg, C Gloeckner, X M Gao, D M Chuang and C J Coscia

Molecular Pharmacology September 1992, 42 (3) 445-452;
You have access
Different calcium-mobilizing receptors share the same guanine nucleotide-binding protein pool in hepatocytes.
L L Dasso and C W Taylor

Molecular Pharmacology September 1992, 42 (3) 453-457;
You have access
Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
M A Cascieri, E Ber, T M Fong, S Sadowski, A Bansal, C Swain, E Seward, B Frances, D Burns and C D Strader

Molecular Pharmacology September 1992, 42 (3) 458-463;
You have access
Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists.
C D Unsworth and P B Molinoff

Molecular Pharmacology September 1992, 42 (3) 464-470;
You have access
Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain.
M A Connor and C Chavkin

Molecular Pharmacology September 1992, 42 (3) 471-479;
You have access
Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
M Morissette, D Lévesque and T Di Paolo

Molecular Pharmacology September 1992, 42 (3) 480-488;
You have access
Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
G Li, H Hidaka and C B Wollheim

Molecular Pharmacology September 1992, 42 (3) 489-488;
You have access
Differential effects of ethanol on electrical properties of various potassium channels expressed in oocytes.
V Anantharam, H Bayley, A Wilson and S N Treistman

Molecular Pharmacology September 1992, 42 (3) 499-505;
You have access
Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin.
T A Noctor, C D Pham, R Kaliszan and I W Wainer

Molecular Pharmacology September 1992, 42 (3) 506-511;
You have access
Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography.
R Kaliszan, T A Noctor and I W Wainer

Molecular Pharmacology September 1992, 42 (3) 512-517;
You have access
Nucleotide specificity of human deoxycytidine kinase.
D S Shewach, K K Reynolds and L Hertel

Molecular Pharmacology September 1992, 42 (3) 518-524;
You have access
Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
L L Bondoc, G Ahluwalia, D A Cooney, N R Hartman, D G Johns and A Fridland

Molecular Pharmacology September 1992, 42 (3) 525-530;
You have access
Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
N W Gibson, J A Hartley, J Butler, D Siegel and D Ross

Molecular Pharmacology September 1992, 42 (3) 531-536;
You have access
Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
J Cerny, S A Foster and Y C Cheng

Molecular Pharmacology September 1992, 42 (3) 537-544;
You have access
Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
S Chen and X F Liu

Molecular Pharmacology September 1992, 42 (3) 545-548;